Δ32 Mutation of the Chemokine-Receptor 5 Gene in Inflammatory Bowel Disease

Author： Martin K.   Heinzlmann M.   Borchers R.   Mack M.   Loeschke K.   Folwaczny C.  

Publisher： Academic Press

ISSN： 1521-6616

Source： Clinical Immunology, Vol.98, Iss.1, 2001-01, pp. : 18-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of the chemokine receptor CCR5- 32 gene mutation in periodontal disease

By Folwaczny M.   Glas J.   Torok H.-P.   Fricke K.   Folwaczny C.  

Clinical Immunology, Vol. 109, Iss. 3, 2003-12 ,pp. : 325-329

Elsevier

Access to resources Recommend Favorite

Atypical Chemokine Receptors in Inflammatory Disease

By  

Current Molecular Medicine, Vol. 9, Iss. 1, 2009-01 ,pp. : 86-93

Bentham Science Publishers

Access to resources Recommend Favorite

A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility

By Song Gwan Gyu   Lee Young Ho  

Immunological Investigations, Vol. 43, Iss. 4, 2014-05 ,pp. : 299-311

Informa Healthcare

Access to resources Recommend Favorite

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer

By Svrcek Magali   Cosnes Jacques   Tiret Emmanuel   Bennis Malika   Parc Yann   Fléjou Jean-François  

Virchows Archiv, Vol. 450, Iss. 2, 2007-02 ,pp. : 243-244

Springer Publishing Company

Access to resources Recommend Favorite

Polymorphisms of the ICAM-1 Gene Are Associated with Inflammatory Bowel Disease, Regardless of the p-ANCA Status

By Braun C.   Zahn R.   Martin K.   Albert E.   Folwaczny C.  

Clinical Immunology, Vol. 101, Iss. 3, 2001-12 ,pp. : 357-360

Academic Press

Access to resources Recommend Favorite